FDA clears first clinical study for a polymicrobial phage library-based treatment for antibiotic-resistant infections

This article was originally published here

The Phase 1/2 trial represents the first study of an expanding phage library under FDA allowance for a multi-site study of intravenous administration and/or bladder instillation of phage

The post FDA clears first clinical study for a polymicrobial phage library-based treatment for antibiotic-resistant infections appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply